Neurodegenerative disorders are significantly increasing in incidence as the age of the
global population continues to climb with improved life expectancy. At present, more than 30 …

Amyloid-β peptide (Aβ) is still best known as a molecule to cause Alzheimer's disease (AD)
through accumulation and deposition within the frontal cortex and hippocampus in the brain …

Abstract DL-3-n-Butylphthalide (DL-NBP), a small molecular compound extracted from the
seeds of Apium graveolens Linn (Chinese celery), has been shown to exert neuroprotective …

Safe and effective cell delivery remains one of the main challenges in cell-based therapy of
neurodegenerative disorders. Graft survival, sufficient enrichment of therapeutic cells in the …

Mesenchymal stem/stromal cells (MSCs) are becoming increasingly important for the
development of cell therapeutics in regenerative medicine. Featuring immunomodulatory …

Erythropoietin (EPO), the main hemopoietic hormone synthesized by the kidney as well as
by the liver in fetal life, is implicated in mammalian erythropoiesis. Production and secretion …

In view of the rapid preclinical development of cell-based therapies for neurodegenerative
disorders, traumatic brain injury, and tumors, the safe and efficient delivery and targeting of …

Mesenchymal stem cell (MSC) transplantation represents the next breakthrough in the
treatment of currently intractable and devastating neonatal disorders with complex …

Central nervous system microglia promote neuronal regeneration and sequester toxic β-
amyloid (Aβ) deposition during Alzheimer's disease. We show that the cytokine …

The human population is increasingly facing various diseases, including types of cancer,
that cannot be cured with conventional drugs. Advanced drug targeting of tumor cells is also …